Renaissance Technologies - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 64 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$74,000
+37.0%
239,061
+76.9%
0.00%
Q4 2019$54,000
-81.3%
135,129
+174.1%
0.00%
Q2 2018$289,0000.0%49,3000.0%0.00%
Q1 2018$289,000
+117.3%
49,300
+71.4%
0.00%
Q4 2017$133,000
-58.2%
28,757
-50.3%
0.00%
Q3 2017$318,000
+189.1%
57,900
+202.0%
0.00%
Q2 2017$110,000
-91.9%
19,171
-91.9%
0.00%
-100.0%
Q1 2017$1,358,000
+40.3%
235,290
+28.1%
0.00%0.0%
Q4 2016$968,000
+674.4%
183,700
+193.5%
0.00%
Q3 2016$125,000
+28.9%
62,600
+85.3%
0.00%
Q4 2015$97,000
-23.6%
33,786
+86.7%
0.00%
Q4 2014$127,00018,1000.00%
Other shareholders

There were no reported owners of CONATUS PHARMACEUTICALS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of CONATUS PHARMACEUTICALS INC shareholders